Clinical trial · Interventional
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI
NCT00874458CI-TRIAL-00110494completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread. PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women with ductal carcinoma in situ.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| magnetic resonance imaging | Procedure | — | UNRESOLVED |
| radiomammography | Procedure | — | UNRESOLVED |
| ultrasound imaging | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- MRI
- interventionNames
- Procedure: magnetic resonance imaging
- Procedure: radiomammography
- Procedure: ultrasound imaging
Primary outcomes (1)
- measure
- Correlation of tumor extension by MRI with surgical histology
- timeFrame
- up to 1 year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of ductal breast carcinoma in situ * Any grade disease allowed * Unifocal disease by mammography * No history of breast cancer * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * WHO performance status 0-2 * Glomerular filtration rate ≥ 30 mL/min * Not pregnant or nursing * Fertile patients must use effective contraception * No allergy or contraindication to contrast MRI * No pacemaker or vascular clip PRIOR CONCURRENT THERAPY: * No prior or concurrent liver transplantation
References
Publications (1)
- RESULTMarcotte-Bloch C, Balu-Maestro C, Chamorey E, Ettore F, Raoust I, Flipo B, Chapellier C. MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients. Eur J Radiol. 2011 Mar;77(3):462-7. doi: 10.1016/j.ejrad.2009.09.003. Epub 2009 Nov 6. PMID 19896789